Proteopath GmbH
Industry / private company
Location:
Trier,
Germany (DE)
ISNI: -
Mass Spectrometry Imaging Differentiates Chromophobe Renal Cell Carcinoma and Renal Oncocytoma with High Accuracy (2020)
Kriegsmann M, Casadonte R, Maurer N, Stoehr C, Erlmeier F, Moch H, Junker K, et al.
Journal article
Development of a Class Prediction Model to Discriminate Pancreatic Ductal Adenocarcinoma from Pancreatic Neuroendocrine Tumor by MALDI Mass Spectrometry Imaging (2019)
Casadonte R, Kriegsmann M, Perren A, Baretton G, Deininger SO, Kriegsmann K, Welsch T, et al.
Journal article
Imaging mass spectrometry analysis of renal amyloidosis biopsies reveals protein co-localization with amyloid deposits (2015)
Casadonte R, Kriegsmann M, Deininger SO, Amann KU, Paape R, Belau E, Suckau D, et al.
Journal article